Edition:
United Kingdom

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

87.04USD
18 Jan 2019
Change (% chg)

$1.94 (+2.28%)
Prev Close
$85.10
Open
$85.95
Day's High
$87.32
Day's Low
$85.95
Volume
751,581
Avg. Vol
346,274
52-wk High
$116.43
52-wk Low
$78.97

Latest Key Developments (Source: Significant Developments)

Quest Diagnostics-Raises Dividend By 6 Pct To An Annual Rate Of $2.12 Per Share
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Quest Diagnostics Inc ::RAISES DIVIDEND BY 6% TO AN ANNUAL RATE OF $2.12 PER SHARE.2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.57 BILLION.CASH PROVIDED BY OPERATIONS NOW EXPECTED TO APPROXIMATE $1.25 BILLION IN 2018.QUEST DIAGNOSTICS - 2018 REPORTED DILUTED EPS EXPECTED TO BE GREATER THAN $5.34, ADJUSTED DILUTED EPS EXPECTED TO BE GREATER THAN $6.30.FY2018 EARNINGS PER SHARE VIEW $6.56, REVENUE VIEW $7.62 BILLION -- REFINITIV IBES DATA.  Full Article

Quest Diagnostics to build flagship laboratory at Visionary Campus in Clifton
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO BUILD FLAGSHIP LABORATORY AT VISIONARY CAMPUS IN CLIFTON, NEW JERSEY TO EMPOWER BETTER HEALTH FOR PATIENTS IN SEVEN STATES.QUEST DIAGNOSTICS - NEW LABORATORY WILL EMPLOY MORE THAN 1,100 PEOPLE.QUEST DIAGNOSTICS INC - NEW LABORATORY IS EXPECTED TO BE OPERATIONAL IN EARLY 2021.  Full Article

Quest Diagnostics To buy Laboratory Services Business Of Boyce And Bynum Pathology Laboratories
Tuesday, 27 Nov 2018 

Nov 27 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO ACQUIRE THE LABORATORY SERVICES BUSINESS OF BOYCE AND BYNUM PATHOLOGY LABORATORIES, EXPANDING DIAGNOSTIC INNOVATION IN THE MIDWEST.QUEST DIAGNOSTICS INC - ADDITIONAL FINANCIAL TERMS OF TRANSACTION WERE NOT DISCLOSED..  Full Article

Quest Diagnostics Reports Q3 Reported Diluted EPS Of $1.53
Tuesday, 23 Oct 2018 

Oct 23 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.THIRD QUARTER REVENUES OF $1.89 BILLION, UP 1.8% FROM 2017.UPDATES OUTLOOK FOR FULL-YEAR 2018.THIRD QUARTER REPORTED DILUTED EPS OF $1.53.SEES FY 18 REPORTED DILUTED EPS NOW EXPECTED TO BE BETWEEN $5.57 AND $5.64.THIRD QUARTER ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION OF $1.68.SEES FY 2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.62 BILLION.SEES FY 18 ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION EXPENSE NOW EXPECTED TO BE BETWEEN $6.53 AND $6.60.  Full Article

Oxford Immunotec Sells U.S. Lab Services Business For $170 Mln To Quest Diagnostics - SEC Filing
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Quest Diagnostics Inc ::OXFORD IMMUNOTEC GLOBAL PLC - TO SELL ITS U.S. LABORATORY SERVICES BUSINESS FOR GROSS PROCEEDS OF $170 MILLION IN CASH TO QUEST DIAGNOSTICS - SEC FILING.OXFORD IMMUNOTEC GLOBAL PLC - WILL UPDATE FULL YEAR 2018 REVENUE GUIDANCE UPON CLOSING OF TRANSACTION.  Full Article

Quest To Acquire U.S. Laboratory Services Business Of Oxford Immunotec
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO ACQUIRE U.S. LABORATORY SERVICES BUSINESS OF OXFORD IMMUNOTEC.QUEST DIAGNOSTICS INC - PARTIES EXPECT TO ENTER INTO A STRATEGIC COLLABORATION AGREEMENT TO DRIVE CONTINUED GROWTH OF T-SPOT.TB TESTING IN U.S.QUEST DIAGNOSTICS INC - INTENDS TO CONTINUE TO OFFER QUANTIFERON TB BLOOD TESTING SERVICES TO PROVIDE PHYSICIANS CHOICE IN BLOOD-BASED TB TESTING.QUEST DIAGNOSTICS - OXFORD IMMUNOTEC TO SELL T-SPOT.TB TEST KITS & RELATED ACCESSORIES TO CO UNDER TERMS OF A LONG-TERM SUPPLY AGREEMENT.  Full Article

Quest Diagnostics Acquires Reprosource
Monday, 24 Sep 2018 

Sept 24 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS ACQUIRES REPROSOURCE, EXTENDING INTO ADVANCED FERTILITY DIAGNOSTICS.QUEST DIAGNOSTICS INC - ADDITIONAL TERMS WERE NOT DISCLOSED..  Full Article

Provant Health Enters Into Asset Purchase Agreement With Summit Health
Monday, 27 Aug 2018 

Aug 27 (Reuters) - Quest Diagnostics Inc ::PROVANT HEALTH ENTERS INTO ASSET PURCHASE AGREEMENT WITH SUMMIT HEALTH, UNIT OF QUEST DIAGNOSTICS.HOOPER HOLMES - QUEST ASSET PURCHASE AGREEMENT IS VALUED AT $27 MILLION, TAKES FORM OF A "STALKING HORSE" BID.HOOPER HOLMES - IN CONJUNCTION WITH SALE PROCESS, CO PETITIONED FOR CHAPTER 11 BANKRUPTCY ON MONDAY, AUG. 27.HOOPER HOLMES - QUEST ASSET PURCHASE DEAL CONTAINS TRANSITION SERVICES AGREEMENT THROUGH DEC. 31.  Full Article

UnitedHealthcare Establishes Partnership With Quest Diagnostics
Thursday, 24 May 2018 

May 24 (Reuters) - Quest Diagnostics Inc ::UNITEDHEALTHCARE ESTABLISHES LONG-TERM STRATEGIC PARTNERSHIP WITH QUEST DIAGNOSTICS.QUEST DIAGNOSTICS INC - CO, UNITEDHEALTHCARE HAVE ESTABLISHED A LONG-TERM STRATEGIC PARTNERSHIP.  Full Article

Quest Diagnostics provides update on impact of 2018 Medicare payment rates
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Quest Diagnostics Inc ::Quest Diagnostics provides update on impact of final 2018 Medicare payment rates for clinical laboratory tests.Quest Diagnostics Inc - ‍expects impact of final fee schedule rates under Protecting Access To Medicare Act​ (PAMA) to be about 4% in 2018.Quest Diagnostics Inc - ‍expects impact of final fee schedule rates under PAMA to be about 10% in 2019 and 2020.  Full Article

RPT-EXPLAINER-Why it’s so hard to diagnose Zika

CHICAGO, Oct 17 When a Zika epidemic was at its height in the Americas two years ago, diagnostics makers began working feverishly to create diagnostic tests for a virus that few in the U.S. had heard of.